Exploring the Role of Topical ET-02 in Androgenic Alopecia
Eirion Therapeutics Inc.’s topical ET-02 may be more effective than existing treatments for androgenic alopecia, according to results of a first-in-man clinical trial. ET-02 restores normal function to hair follicle stem cells that have become inactive in age-related hair loss due to a defect that develops in the stem cell biology. By correcting this defect […]